NeoMed holds globally recognized ISO 13485:2016 certifications from the prestigious British Standards Institution (BSI). This certification includes the Standards Council of Canada (SCC) endorsement under Canadian Medical Device Conformity Assessment System (CMDCAS) scheme. In addition to ISO 13485:2016, the company quality system is established and maintained to comply with the European Medical Devices Directive 93/42/EEC, and U.S. FDA Quality System Regulations, 21CFR Part 820.
NeoMed has received market authorization from the U.S. FDA, Health Canada, the European Union, New Zealand's Medicines and Medical Device Safety Authority (MedSafe), and the Therapeutics Goods Administration of Australia.
Click the following links to view each document as specified below.
BSI ISO 13485:2016 Certificate # FM 553493
MDSAP Certificate: 662076
BSI CE Certificate #569269
USA FDA Cleared 510(k) Numbers: K072997, K073596, K081515, K082238, K092908, K100288, K072881, K120182, K122373, K120182, K143344, K152857, K161039